RRML - OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- August 2020 -
 
Romanian Review of Laboratory ... 8
Metabolomic biomarkers of poly... 6
Mucopolysaccharidosis type I -... 4
Carbapenemase Producing Entero... 3
Total Errors of TSH results by... 3
High frequency of BRCA recurre... 3
Evaluation of Diagnostic Tests... 2
Plasma levels of resistin pred... 2
Multiplex ligation dependent p... 2
The usefulness of neutrophil/l... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 25(1)/2017 DOI:10.1515/rrlm-2017-0006
XML
TXT

Short communication

OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases

Cristina Popescu, Gabriel Adrian Popescu, Olga Dorobăț, Alexandru Rafila, Diana Tănase, Claudia Mikula, Gudrun Weissensteiner, Steliana Huhulescu

Correspondence should be addressed to: Gabriel Adrian Popescu

Abstract:

We report first description of clinical cases of OXA-48 carbapenemase-producing Klebsiella pneumoniae originating from patients hospitalized in the most important Infectious Diseases Hospital from Romania, between December 2012 and March 2013. All strains were isolated from patients who were previously admitted in surgical wards. None of the patients had been admitted in a hospital outside of Romania.

Keywords: Klebsiella pneumoniae; OXA-48 carbapenemase;ESBL; risk factors for resistance

Received: 28.10.2016
Accepted: 14.1.2017
Published: 15.1.2017

 
  PDF Download full text PDF
(320 KB)
     
 
How to cite
Popescu C, Popescu GA, Dorobăț O, Rafila A, Tănase D, Mikula C, et al. OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases. Rev Romana Med Lab. 2017;25(1):55-61. DOI:10.1515/rrlm-2017-0006